Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.025 | 0.9 |